Eric W. Roberts - 01 Jun 2023 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Role
Chief Business Officer, Director, 10%+ Owner
Signature
By John Dunn, Attorney-in-Fact
Issuer symbol
CALC
Transactions as of
01 Jun 2023
Net transactions value
+$17,096
Form type
4
Filing time
05 Jun 2023, 19:20:39 UTC
Previous filing
01 Jun 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CALC Common Stock Purchase $8,830 +2,000 +24% $4.42 10,500 01 Jun 2023 Direct F1
transaction CALC Common Stock Purchase $8,266 +1,687 +16% $4.90 12,187 02 Jun 2023 Direct F2
holding CALC Common Stock 8,000 01 Jun 2023 By Oppenheimer & Co Inc. Custodian FBO Eric W Roberts Roth IRA
holding CALC Common Stock 1,800 01 Jun 2023 By FMTC Custodian - Roth IRA FBO Eric W. Roberts
holding CALC Common Stock 10,661 01 Jun 2023 By IRA Financial Trust Company CFBO Eric W. Roberts
holding CALC Common Stock 356,989 01 Jun 2023 By Valence Investments SPV IV, LLC F3
holding CALC Common Stock 66,228 01 Jun 2023 By Valence Investments SPV V, LLC F3
holding CALC Common Stock 316,109 01 Jun 2023 By Valence Investments SPV VI, LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $4.415, and the range of prices were between $4.37 and $4.43. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 The weighted average purchase price for the transaction reported was $4.9, and the range of prices were between $4.97628 and $4.9. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
F3 The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of his pecuniary interest therein.